Medical Devices
- 1330.264
- +18.821+1.44%
Medtronic Upgraded at UBS on Diabetes Turnaround
Lake Street Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $6
Lake Street Initiates ReWalk Robotics(LFWD.US) With Buy Rating, Announces Target Price $8.5
A Quick Look at Today's Ratings for NeuroPace(NPCE.US), With a Forecast Between $8 to $20
Lake Street Remains a Buy on Rewalk Robotics (LFWD)
Lake Street Remains a Buy on Accuray (ARAY)
Maxim Group Maintains Venus Concept(VERO.US) With Hold Rating
Maxim Group Maintains Nuwellis(NUWE.US) With Hold Rating
Maxim Group Maintains PAVmed(PAVM.US) With Buy Rating
Roth MKM Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $7
Truist Financial Maintains AdaptHealth(AHCO.US) With Buy Rating, Announces Target Price $13
Accuray (ARAY) Receives a Buy From Roth MKM
Maxim Group Keeps Their Hold Rating on Nuwellis (NUWE)
CCORF Maintains Delcath Systems(DCTH.US) With Buy Rating, Maintains Target Price $21
Benchmark Downgrades Movano to Speculative Buy, $2 Price Target
Buy Rating Affirmed for Delcath Systems Amidst Strong Hepzato Launch and Promising Future Prospects
Barclays Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $93
Truist Financial Maintains Globus Medical(GMED.US) With Hold Rating
Oppenheimer Maintains Globus Medical(GMED.US) With Hold Rating, Raises Target Price to $73
BTIG Maintains Accuray(ARAY.US) With Buy Rating, Maintains Target Price $6